All Stories

  1. The impact of removing a ban on electronic nicotine delivery systems using the Mexico smoking and vaping model (SAVM)
  2. Cross-state Border Nicotine Vaping Products Purchase – Early Evidence from State Emergency Sales Restrictions in 2019
  3. How do users compare the costs between nicotine vaping products and cigarettes? Findings from the 2016–2020 International Tobacco Control United States surveys
  4. Cigarette Prices and Disparities in Cessation in the United States
  5. The smoking and vaping model, A user-friendly model for examining the country-specific impact of nicotine VAPING product use: application to Germany
  6. Modeling the future of tobacco control: Using SimSmoke to explore the feasibility of the tobacco endgame in Korea
  7. Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
  8. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International
  9. The longitudinal association between coupon receipt and established cigarette smoking initiation among young adults in USA
  10. Are the Relevant Risk Factors Being Adequately Captured in Empirical Studies of Smoking Initiation? A Machine Learning Analysis Based on the Population Assessment of Tobacco and Health Study
  11. Birth Cohort‒Specific Smoking Patterns by Family Income in the U.S.
  12. Patterns of Birth Cohort‒Specific Smoking Histories by Race and Ethnicity in the U.S.
  13. Patterns of Birth Cohort‒Specific Smoking Histories in Brazil
  14. Summary and Concluding Remarks: Patterns of Birth Cohort‒Specific Smoking Histories
  15. Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study
  16. Using the Past to Understand the Future of U.S. and Global Smoking Disparities: A Birth Cohort Perspective
  17. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015–2017 vs 2017–2019
  18. Cigarettes, ENDS Use, and Chronic Obstructive Pulmonary Disease Incidence: A Prospective Longitudinal Study
  19. Do Tobacco Companies Have an Incentive to Promote “Harm Reduction” Products?: The Role of Competition
  20. Chemical Profiles and Toxicity of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
  21. An exploration of flavours in studies of e‐cigarettes for smoking cessation: secondary analyses of a systematic review with meta‐analyses
  22. The Longitudinal Association Between Cigarette Coupon Receipt and Short-term Smoking Cessation Among US Adults
  23. Do Current Smokers and Ex-Smokers Who Use Nicotine Vaping Products Daily Versus Weekly Differ on Their Reasons for Vaping? Findings from the 2020 ITC Four Country Smoking and Vaping Survey
  24. A Decision-Theoretic Public Health Framework for Heated Tobacco and Nicotine Vaping Products
  25. Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018–2019 Survey
  26. Impact of vaping restrictions in public places on smoking and vaping in the United States—evidence using a difference‐in‐differences approach
  27. The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products
  28. Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among Adults
  29. Health Effects of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
  30. Public health impact of a US menthol cigarette ban on the non-Hispanic black population: a simulation study
  31. An analysis of cigarette sales during Poland’s menthol cigarette sales ban: small effects with large policy implications
  32. The Impact of Current Tobacco Product Use Definitions on Estimates of Transitions Between Cigarette and ENDS Use
  33. Impact of Canada’s menthol cigarette ban on quitting among menthol smokers: pooled analysis of pre–post evaluation from the ITC Project and the Ontario Menthol Ban Study and projections of impact in the USA
  34. Follow the money: a closer look at US tobacco industry marketing expenditures
  35. Trends in Exclusive, Dual and Polytobacco Use among U.S. Adults, 2014–2019: Results from Two Nationally Representative Surveys
  36. Poland is not replicating the HTP experience in Japan: a cautionary note
  37. Cigarette Pack Price and Its Within-Person Association With Smoking Initiation, Smoking Progression, and Disparities among Young Adults
  38. A longitudinal analysis of smoke‐free laws and smoking initiation disparities among young adults in the United States
  39. Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study
  40. Tobacco retail availability and cigarette and e-cigarette use among youth and adults: a scoping review
  41. Sociodemographic Patterns of Exclusive and Dual Use of ENDS and Menthol/Non-Menthol Cigarettes among US Youth (Ages 15–17) Using Two Nationally Representative Surveys (2013–2017)
  42. Response to Braillon (2021): No, not the exception
  43. The Mexico SimSmoke tobacco control policy model: Development of a simulation model of daily and nondaily cigarette smoking
  44. An Expert Elicitation on the Effects of a Ban on Menthol Cigarettes and Cigars in the United States
  45. US Nicotine Vaping Product SimSmoke Simulation Model: The Effect of Vaping and Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths
  46. Public health implications of vaping in the USA: the smoking and vaping simulation model
  47. Public Health Implications of Vaping in The US: The Smoking and Vaping Simulation Model
  48. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study
  49. An Analysis of the Altria-Juul Labs Deal: Antitrust and Population Health Implications
  50. E-cigarettes and Cessation: Asking Different Questions Requires Different Methods
  51. Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1–4): multistate transition modelling accounting for complex survey design
  52. The Kentucky SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use
  53. England SimSmoke: the impact of nicotine vaping on smoking prevalence and smoking‐attributable deaths in England
  54. Patterns of E-cigarette Use and Subsequent Cigarette Smoking Cessation Over 2 Years (2013/2014–2015/2016) in the Population Assessment of Tobacco and Health Study
  55. The actual and anticipated effects of a menthol cigarette ban: a scoping review
  56. The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes
  57. Support for Minimum Legal Sales Age Laws Set to Age 21 Across Australia, Canada, England, and United States: Findings From the 2018 ITC Four Country Smoking and Vaping Survey
  58. Public Health Implications of Vaping in the US: The Smoking and Vaping Simulation Model
  59. Taxation reduces smoking but may not reduce smoking disparities in youth
  60. Vaping popularity did not increase smoking rate
  61. Costs of vaping: evidence from ITC Four Country Smoking and Vaping Survey
  62. Smoking trends in Mexico, 2002–2016: before and after the ratification of the WHO’s Framework Convention on Tobacco Control
  63. Tobacco 21 Laws in Europe: A Policy Whose Time Has Come
  64. The Minnesota SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use
  65. Altria-Juul Labs deal: why did it occur and what does it mean for the US nicotine delivery product market
  66. Impact of nations meeting the MPOWER targets between 2014 and 2016: an update
  67. The US SimSmoke tobacco control policy model of smokeless tobacco and cigarette use
  68. The need for a comprehensive framework
  69. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products